| Literature DB >> 23126230 |
Joshua K Stone1, Mark Mayo, Stephanie A Grasso, Jennifer L Ginther, Stephanie D Warrington, Christopher J Allender, Adina Doyle, Shalamar Georgia, Mirjam Kaestli, Stacey M Broomall, Mark A Karavis, Joseph M Insalaco, Kyle S Hubbard, Lauren A McNew, Henry S Gibbons, Bart J Currie, Paul Keim, Apichai Tuanyok.
Abstract
BACKGROUND: Burkholderia pseudomallei is the etiological agent of melioidosis and a CDC category B select agent with no available effective vaccine. Previous immunizations in mice have utilized the lipopolysaccharide (LPS) as a potential vaccine target because it is known as one of the most important antigenic epitopes in B. pseudomallei. Complicating this strategy are the four different B. pseudomallei LPS O-antigen types: A, B, B2, and rough. Sero-crossreactivity is common among O-antigens of Burkholderia species. Here, we identified the presence of multiple B. pseudomallei O-antigen types and sero-crossreactivity in its near-neighbor species.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23126230 PMCID: PMC3541218 DOI: 10.1186/1471-2180-12-250
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Prevalence of four O-antigen types in near-neighbors
| 23 | 21 | 0 | 0 | 2 | |
| 4 | 1 | 0 | 0 | 0 | |
| 12 | 11 | 0 | 1† | 0 | |
| 5 | 0 | 0 | 4 | 0 | |
| 2 | 0 | 0 | 0 | 0 | |
| 3 | 0 | 0 | 0 | 0 | |
| 44 | 0 | 11 | 1‡ | 0 | |
| 1 | 0 | 0 | 0 | 0 | |
| 19 | 0 | 0 | 1* | 0 | |
†Strain 82172, collected from French foal.
‡Strain MSMB108, collected from Northern Australian environment.
*Strain MSMB175, a soil strain collected from Australia. This strain is currently being proposed as a new Burkholderia species.
Figure 1Serotype A (a) and B (b) western blots. Lane 1 – B. pseudomallei K96243, 2 – B. thailandensis E264, 3 – B. oklahomensis E0147, 4 – B. pseudomallei 576, 5 – B. ubonensis MSMB57, 6 – B. pseudomallei MSHR840, 7 – B. thailandensis 82172, 8 – B. thailandensis-like MSMB122, 9 – B. ubonensis MSMB108, 10 – Burkholderia sp. MSMB175, 11 – B. thailandensis-like MSMB43. Lanes 1–3 are representative of type A strains, Lanes 4–5 are representative of type B strains, Lanes 6–10 are representative of type B2 strains, and Lane 11 contains an unknown serotype B O-antigen
Figure 2Genomic comparison of O-antigen serotype B biosynthesis genes. Gene clusters, from top to bottom, of B. pseudomallei 576 (type B), B. ubonensis MSMB57 (type B), B. thailandensis-like MSMB43 (type B variant), Burkholderia sp. MSMB175 (type B2), B. thailandensis-like MSMB122 (type B2), B. thailandensis 82172 (type B2), B. pseudomallei MSHR840 (type B2), and B. pseudomallei 576 were used to illustrate the diversity of the serotype B O-antigen biosynthesis gene clusters. Red indicates homology of 78-100% and blue indicates an inversion region with equal homology
Figure 3Serum sensitivity of near-neighbors.B. thailandensis E264, MSMB59, MSMB60 and B. oklahomensis E0147 showed a slight resistance to killing by 30% NHS while all other strains were susceptible to killing, especially B. ubonensis MSMB108. This is in agreement with prior studies showing serum sensitivity of B. pseudomallei strains expressing type B2 or rough type O-antigens. Note: Bt, B. thailandensis; Bt-like, B. thailandensis-like species; Bu, B. ubonensis; Bok, B. oklahomensis; and B.sp, Burkholderia sp